Dilantin Lawsuit Triggers Class Action from Long Term Side Effects

1
M A T C H L A W S U I T S
C L A I M S
S E T T L E M E N T S
CLAIMS MATCH
M I L L I O N S I N U N C L A I M E D A W A R D S
A W A I T V A L I D C L A I M S
2
Dilantin Lawsuit Triggers Class Action from Long
Term Side Effects
Add a subheading
3
DILANTIN
Phenytoin or Dilantin Side Effects Dilantin
(also known as Phenytoin) is an anticonvulsant
medicine applied to treat patients suffering
from epilepsy or seizures. Yet, scientists and
class action attorneys have informed the public
that long-term Phenytoin use may lead to birth
defects and may cause serious medical
complications that can permanently alter a
persons movement, speech, and
coordination. Excessive Dilantin treatments can
further produce debilitating pain, scarring,
blindness, organ failure and sometimes death..
4
1. Hives, boils or red spots around the mouth.
OTHER SYS AND TEN SYMPTOMS FROM PHENYTOIN
REACTIVITY MAY INCLUDE

• Blisters inside the nose
• Swelling of the eyelids
• Flu-related symptoms
• Widespread skin pain
• Facial or tongue swelling
• Dilantin SJS may further cause blindness if scar
  tissue forms behind the eyelids and pulls on the
  victims cornea.

5
Phenytoin Toxicity In The News
Products liability authorities have also studied
Dilantin toxicity attachments to a more severe
medical condition called cerebellar atrophy. In
2008, The Journal of Clinical Pharmacy and
Therapeutics published research that documented
cases linking Dilantin to rear brain dysfunctions
and cerebellar lesions.
6
Some Notable Dilantin Lawsuits And Settlements
Include
April 1998A Massachusetts citizen sued Pfizer
after Phenytoin toxicity caused TEN to form in
over ninety percent of her body and induced
blindness the courts awarded this plaintiff
140 million in damages.
Pfizer Phenytoin Class Action Settlements
The FDA approved Phenytoin in 1953 for seizure
treatment but it was only when healthcare
professionals made their 2008 SYS-Dilantin
toxicity study public that the The Agency
compelled Pfizer to publish new warnings about
the drugs potential adverse toxicity links to
SYS and TEN.
November 2010Pfizer settles a 4 million
lawsuit with the estate of an SJS victim who
died less than one month after taking
Phenytoin. January 2010, an SJS patient in Ohio
won a comparable 10 million jury award for
cerebellar shrinkage complications. There are
over 120 Dilantin SJS individual and class
action lawsuits filed and pending.
The drugmaker compiled by only adding data
suggests that individuals of Asian ancestry who
carry the gene allele HLA-B1602 may face a
substantially increased risk of the Dilantin skin
problems to its warning labels.
7
(No Transcript)